Drive increased adherence through holistic patient support programs

EAP launch

Many pharma companies are turning to patient support programs to improve patient outcomes, boost relationships with healthcare providers and ensure optimum brand success. Pharmaceutical patient support programs are a powerful way to strengthen patient care, ensuring they adhere to their treatment plan, and helping them to develop knowledge and skills to manage their condition and treatment more autonomously and effectively.

Sciensus is a leading provider of patient support programs (PSPs) across cancer, rare diseases and long-term conditions. Guided by more than 70 million patient interactions, we’ve shown that combining digital solutions with a human touch provides a more personalised patient experience. This approach is key to helping patients adhere to their treatment plans and improve their health outcomes overall. Additionally, through our patient-facing applications, we generate key insights that enable us to drive the right interventions at the right time, further enhancing the effectiveness of our PSPs.

Schedule a free consultation

What are patient support programs?

These programs provide patients, caregivers and healthcare professionals with resources, tools and services, both digitally and in-person, that go beyond the medication itself. PSPs support patients throughout their treatment journey, focusing on areas such as adherence, education, emotional wellbeing and access to care. They are a vital tool in the overall health ecosystem that can help ensure treatments are as effective as they possibly can be.

Modern healthcare demands a new approach to patient support that addresses key industry challenges:

  • Complex, targeted therapies requiring sophisticated patient education and support
  • Limited treatment adherence impacting clinical outcomes
  • Disconnected healthcare experiences across different touchpoints
  • Difficulty demonstrating real-world treatment value

Types of patient support programs

Patient education programs

In Europe, where healthcare is largely state-funded, patient support programs are commonly driven by the potential for severe side effects and risk to patient safety, or adherence to their treatment. In these cases, patients must be closely monitored and supported after being educated fully about the potential side effects of their medicine and associated risks.

Patient support programs can also help with disease and symptom management through complementary therapies, emotional support, and enhanced training for patients and their families.

Patient assistance programs

In the US, patient assistance programs can be used to support access to medication from a financial perspective. This may include managing insurance issues and providing support to secure financial assistance.

Benefits of patient support programs

Effective PSPs provide seamless onboarding, helping patients start therapy quickly. They offer smart tools to support adherence, ensuring patients stick with treatment, and deliver tailored education to promote proper use. By incorporating symptom tracking and early collection of patient-reported data, these programs not only improve outcomes but also build prescriber confidence and demonstrate value to healthcare systems.

patient support programs
Drive treatment initiation and brand adoption

Effective PSPs provide seamless onboarding, helping patients start therapy quickly. They offer smart tools to support adherence, ensuring patients stick with treatment, and deliver tailored education to promote proper use. By incorporating symptom tracking and early collection of patient-reported data, these programs not only improve outcomes but also build prescriber confidence and demonstrate value to healthcare systems.

patient support programs
Maximise stakeholder engagement and brand value

Programs that combine omnichannel tools with digital platforms are perfectly positioned to provide personalised, interactive support that helps patients manage their conditions more effectively. At the same time, they reduce the burden on healthcare professionals by streamlining patient management. These programs lead to better patient experiences, more therapy starts and higher persistence.

patient support programs
Optimise healthcare delivery and market access

Healthcare systems are stretched and PSPs that align with clinician workflows, improve efficiency and provide compelling real-world evidence stand out. Regulators and payers increasingly expect this level of integration and support when considering new therapies. By capturing real-world evidence, they also strengthen market access and reinforce a brand’s value.

patient support programs

The Sciensus Digital+ advantage

Combined with a deep understanding of the regulatory landscape, we will build a proposal for a holistic patient support program for your patients and brand. Our comprehensive solutions include:

Connected care ecosystem

We engage with healthcare professionals, patient advocacy groups, charities and key stakeholders in your team to design patient support programs that address the unmet needs of patients and their caregivers. We streamline coordination between patients, clinical team, and homecare services.

Digitally enabled patient support

Persistence with long-term therapy is a recognised challenge, with 50% of patients worldwide not following their prescribed medication. Through a combination of innovative digital tools and in-person support, we provide a comprehensive approach that improves both adherence and health outcomes.

Personalised patient journey support

We offer personalised patient support through a tailored approach, ensuring timely help with treatment, side effect management, and wellbeing resources. This is all coordinated through a digital system that keeps healthcare providers informed and engaged.

Start transforming patient support today

Partner with Sciensus to develop a Digital+ PSP that drives better outcomes for your patients and demonstrates real-world treatment value. Contact our team to schedule a consultation.

Sciensus address - Our locations

Sciensus’ European blueprint

We have a deep understanding of individual regulatory frameworks and can rapidly mobilise our large clinical workforce. We use our in-depth knowledge and clinical expertise to understand your needs, research the condition your product can treat, and highlight any areas of unmet need. From this, we can build a proposal for a holistic patient support program for your product. We engage with patient advocacy groups to understand lived experience and existing support services, as well as reviewing scientific papers and working with opinion leaders to design a program that targets those unmet needs. Once up and running, we collect patient data and report on their experiences of side effects and the treatment’s impact on the disease’s symptoms.

We also manage clinical risks and quality and take a pan-European approach to managing a patient support program. Not only does this mean the same high standards of care are applied to patients across the whole continent, but your program also benefits from being managed through our unified IT system for accurate data capture and reporting.

Proven impact

Our digital ecosystem supports patients throughout their journey.

0 %

Increase in patient medication adherence

0 %

Patient engagement

0 %

Completion of patient-reported outcomes

Why Sciensus?

Unmatched experience

Serving over 240,000 patients a year through our team of over 700 licensed clinical staff, partnering with over 3,000 pharmacies & hospitals.

Connected ecosystem

Leverage our large Europe-wide clinical workforce and well-established relationships with healthcare providers, patient advocacy groups and key opinion leaders across the region.

End-to-end support

Our partners benefit from our expertise in regulatory, marketing, and commercial strategy, ensuring a faster route to market with our bespoke end-to-end solutions.

*We carried out a study across multiple products to understand the impact of digital and in-person support. There was a 17% increase in persistence for patients receiving the combined support of a health and wellbeing app and face-to-face and virtual nursing.

The study demonstrates that Digital Patient Support Programs (DPSPs) with a ‘human touch’ are the right hybrid combination of support with a significant impact on adherence and persistence.